Latest Breaking News On - Delbruck - Page 16 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. . AKAMPIONJanuary 19, 2021 GMT San Francisco, CA / Berlin, Germany – January 19, 2021 T-knife GmbH, a next-generation adoptive T-cell therapy company leveraging its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, today announced the appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer. Elisa Kieback, T-knife’s co-founder and founding CEO, has assumed the role of Chief Technical Officer. “We welcome Tom and Camille to T-knife and look forward to their contributions as we continue to build our best-in-class T-cell receptor platform, advance our pipeline of innovative cell therapies, and transition to becoming a clinical-stage company in 2021,” stated Alexander Mayweg, Ph.D

University of southern californiaUnited statesNordrhein westfalenSan franciscoElisa kiebackLudger wess ines regina buthAscendis pharmaCamillea landisThomasm solowayCamille landisAlexander maywegUniversity of californiaUniversity of stMax delbruck centerBoehringer ingelheim venture fundHaas school